According to performed analyses adjusted for the confounding effects of differences in baseline characteristics, assessment of CPR to neoadjuvant treatment does not improve the capability of selection criteria combining morphologic features with AFP to predict tumor recurrence. This evidence concerns the gene AFP and neoplasm.